TRAF6 and prostate carcinoma: studied an unconventional E3 ligase named TNF-receptor associated factor 6 (TRAF6) and found that RES could inhibit growth and proliferation of prostate cancer cells by regulating the expression of TRAF6, suppressing the EMT process through NF-κB/Slug axis (46).